Conditions: Ewing's Sarcoma Family of Tumors
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 138
Healthy volunteers: no

Brief summary:
Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: CP-751,871
Intervention descriptions: intervention 1: Final dose 30 mg/kg IV on Day 1 of each 28 day cycle until either progression or toxicity

Protocol document: